Background Closed-loop artificial pancreas systems have been in development for several
years, including assessment in numerous varied outpatient clinical trials. We aimed to …

Continuous glucose monitoring (CGM) provides information unattainable by intermittent
capillary blood glucose, including instantaneous real-time display of glucose level and rate …

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies Page 1 ISPAD
CLINICAL PRACTICE CONSENSUS GUIDELINES ISPAD Clinical Practice Consensus …

As intensive treatment to lower levels of HbA1c characteristically results in an increased risk
of hypoglycaemia, patients with diabetes mellitus face a life-long optimization problem to …

The artificial pancreas (closed-loop system) addresses the unmet clinical need for improved
glucose control whilst reducing the burden of diabetes self-care in type 1 diabetes. Glucose …

Background: Closed-loop artificial pancreas device (APD) systems are externally worn
medical devices that are being developed to enable people with type 1 diabetes to regulate …

Aims Hybrid closed‐loop (HCL) systems are characterised by integrating continuous
glucose monitoring (CGM) with insulin pumps that automate insulin delivery via specific …

Background: In the past few years, the artificial pancreas—the commonly accepted term for
closed-loop control (CLC) of blood glucose in diabetes—has become a hot topic in research …

Automated insulin delivery (AID) systems, so-called closed-loop systems or artificial
pancreas, are based upon the concept of insulin supply driven by blood glucose levels and …

Objective: Hybrid closed-loop (HCL) artificial pancreas (AP) systems are now moving from
research settings to widespread clinical use. In this study, the inControl algorithm developed …